Will onglyza's cost decrease with generic launch?

In general, yes—the cost of Onglyza (saxagliptin) tends to go down when a generic version enters the market. But how much and how quickly depends on several factors:

- Country and patent/status of the drug
- How many generic manufacturers enter the market (more competition usually means bigger price drops)
- What insurers and payers negotiate (rebates, formulary placement, copays)
- Out-of-pocket costs for you (your insurance plan, deductible, and any discounts or coupons)

Often you’ll see a noticeable drop over the first year or two after generic launch, but the initial price change can be modest if there isn’t much competition yet or if rebates keep the list price higher. Also, if you’re using a fixed-dose combination product (like a saxagliptin/metformin combo), the price dynamics can be different and may take longer to reflect generic competition.

To tailor this to you, I can check current status for your location if you tell me:
- Which country you’re in (and ideally your city/region)
- Whether you’re asking about list price vs. out-of-pocket cost
- If you’re considering alternatives or need help navigating insurance/copays

If you want immediate steps now:
- Ask your pharmacist or insurer whether a generic saxagliptin is available in your plan.
- Compare prices at a few different pharmacies or look up discount programs (e.g., GoodRx in the U.S. or local equivalents).
- Discuss with your prescriber about alternatives if cost becomes a significant barrier (other DPP-4 inhibitors, or different drug classes, depending on your health needs).